XLR Medical Corp. (XLRM) is in the Financial Services Industry

XLR Medical is a development stage company that has no sources of revenue to provide incoming cash flows to sustain future operations. Co. was primarily involved in a joint venture with Exelar Corporation ("Exelar") for the purpose of developing a patented technology that utilizes small superconducting magnets to focus and control dosages of therapeutic radiation for the treatment of cancerous tumours (the "Technology") up until Sept. 2, 2005. Co. no longer has an interest in the Technology, as a result, Co. is reorganizing its business and seeking new business opportunities.